← Open Payments lookup

KATHLEEN MCCLANAHAN: Open Payments

NPI 1275503633 · HOLLYWOOD, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$228 in 11 payments from 7 companies in 2025. Trend: 2023 $258 · 2024 $355 · 2025 $228

Food & beverage: $228
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.4$78
Merck Sharp & Dohme LLC2$44
AstraZeneca Pharmaceuticals LP1$25
Boehringer Ingelheim Pharmaceuticals, Inc.1$25
Boston Scientific Corporation1$21
Bayer Healthcare Pharmaceuticals Inc.1$18
Novartis Pharmaceuticals Corporation1$17

Products named: ELIQUIS, VERQUVO, FARXIGA, JARDIANCE, CDS - MCT/CEM Monitoring, CAMZYOS, Kerendia, LEQVIO.

Industry payments across MD — which companies pay providers there.